Back to Rare Disease
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT04157595

NCT04157595
Completed Not Applicable 🇦🇺 Australian site

Who may be able to join

Who might be able to join this trial:

  • You and your partner are either planning to become pregnant or are in very early pregnancy (less than 10 weeks along at the time of joining, and less than 11 weeks when your sample reaches the lab).
  • Both you and your partner are willing and able to take part and provide a sample for testing at the same time.
  • If you are using an egg or sperm donor, that donor must also be willing to provide a DNA sample and agree to the carrier screening process.

Who may not be able to join:

  • You are already pregnant and more than 10 weeks along at the time of joining the trial.
  • Only one partner is willing to take part — both must agree to participate.
  • Either partner is under 18 years old.
  • You and your partner are not able to provide your samples at the same time.
  • You are using an egg or sperm donor, but that donor is either not available for testing or is anonymous (identity unknown).
  • One partner has already taken part in this study before.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Murdoch Childrens Research Institute
Registry
clinicaltrials_gov
Start date
21 November 2019
Est. completion
31 March 2022

Where this trial is recruiting

🇦🇺 Australia

24 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Screening Uptake (Quantitative); Frequency of Increased-Risk Couples; Reproductive Choices made by Increased-Risk Couples; Cohort Characteristics of those who decline and those who accept RGCS; Predictors of Uptake - Decliners; Predictors of Uptake - Decliners; Predictors of Uptake - Acceptors; Predictors of Uptake - Acceptors

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov